Loading…
Expanded Coverage for Former Foster Youth Act
Legislative Progress
Introduced
September 19, 2023
Latest Action
September 19, 2023
Primary Sponsor
Robert P. Casey, Jr.Democratic(PA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,649 other S bills in the 118th — cohort avg 33d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2024 · second_quarter · Family issues/Abortion/Adoption
Biden Administration NPRM on child welfare Implementation of the Family First Prevention Services Act Improved process to secure Social Security Cards for children in foster care H.R. 8713 (Kamlager-Dove) S. 4629 (Gillibrand) S. 2837 - Expanded Coverage for Former Foster Youth (Casey) S. 2836 - Foster Youth and Mental Health Act (Casey) S. 2849 - Fostering Success in Higher Education Act (Casey) HR 4531 - The Support Act -- provision related to Qualified Residential Treatment Programs (QRTPs) and the Institutions for Mental Diseases (IMD) exclusion HR 3852 - Create Accountable Respectful Environments (CARE) for children Act (Dunn) HR 5028 - Family Poverty is Not Child Neglect Act (Moore) Parental rights and gender-affirming care as it relates to foster care and CAPTA Reauthorization of Title IV-B of the SSA Implementation of the Family First Prevention Services Act (FFPSA) Interaction between Institutions for Mental Diseases (IMD) with Qualified Residential Treatment programs (QRTPs) -- HR 4056 H.R. 1446/S. 699 -- The Foster Youth and Driving Act Ensuring that children and youth in foster care have access to a Social Security Card H.R 4282 -- to protect individuals with disabilities who are parents, legal guardians, relatives, other caregivers, foster or adoptive parents, or individuals seeking to become foster or adoptive parents from discrimination on the child welfare system Issues associated with the reauthorization of the Child Abuse Prevention and Treatment Act (CAPTA Mental and behavioral health issues for children and youth in foster care Issues associated with the SNAP program S. 3196 -- Ensuring Medicaid Continuity for Children in Foster Care Act HR 2428 the Find and Protect Foster Youth Act HR 3058 the Recruiting Families Using Data Act of 2023 S. 3098 to expand the replacement of stolen EBT benefit under SNAP HR 7010 Increasing Access to Foster Care Through Age 21 Act (Chu) HR 7038 Guaranteed Income for Foster Youth Act (Garcia) Reauthorization of programs in Title IV-B of the Social Security Act H.R.8743 - To amend subpart 2 of part B of title IV of the Social Security Act to promote permanency for youth by strengthening support networks for children, youth, and families at risk of entering the child welfare system. H.R.8745 - To amend part B of title IV of the Social Security Act to improve the monthly caseworker visits program so States can invest in the child welfare workforce ensuring that children in care have access to quality and timely care. H.R.8793 - To gather data on adoptions from foster care and assess the effectiveness of post-adoption services and resources provided to the families, in order to identify gaps in accessible services and inform strategic investments and improve outcomes for adopted children and their families. H.R.8798 - To amend subpart 2 of part B of the Social Security Act to promote community-based prevention services, and for other purposes. H.R.8813 - Preventing Child Welfare Entry Caused by Poverty Act H.R.8814 - To amend part B of title IV of the Social Security Act to establish a competitive grant program to enhance the ability of evidence-based child welfare programs to meet the research standards set by the Family First Prevention Services Clearinghouse, and for other purposes. H.R.8814 - To amend part B of title IV of the Social Security Act to establish a competitive grant program to enhance the ability of evidence-based child welfare programs to meet the research standards set by the Family First Prevention Services Clearinghouse, and for other purposes. H.R.8885 - To amend part B of title IV of the Social Security Act to create a grant program to promote Federal, State, and local coordination to address substance use needs of families in the child welfare system, in order to improve child well-being and permanency. H.R.8890 - To reauthorize the Regional Partnership Grant program under subpart 2 of part B of title IV of the Social Security Act for 5 years, and for other purposes
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $36,000
Government targets: Administration for Children & Families (ACF), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Social Security Administration (SSA), White House Office
2024 · first_quarter · Family issues/Abortion/Adoption
Biden Administration NPRM on child welfare S. 2837 - Expanded Coverage for Former Foster Youth (Casey) S. 2836 - Foster Youth and Mental Health Act (Casey) S. 2849 - Fostering Success in Higher Education Act (Casey) HR 4531 - The Support Act -- provision related to Qualified Residential Treatment Programs (QRTPs) and the Institutions for Mental Diseases (IMD) exclusion HR 3852 - Create Accountable Respectful Environments (CARE) for children Act (Dunn) HR 5028 - Family Poverty is Not Child Neglect Act (Moore) Parental rights and gender-affirming care as it relates to foster care and CAPTA Reauthorization of Title IV-B of the SSA Implementation of the Family First Prevention Services Act (FFPSA) Interaction between Institutions for Mental Diseases (IMD) with Qualified Residential Treatment programs (QRTPs) -- HR 4056 H.R. 1446/S. 699 -- The Foster Youth and Driving Act Ensuring that children and youth in foster care have access to a Social Security Card H.R 4282 -- to protect individuals with disabilities who are parents, legal guardians, relatives, other caregivers, foster or adoptive parents, or individuals seeking to become foster or adoptive parents from discrimination on the child welfare system Issues associated with the reauthorization of the Child Abuse Prevention and Treatment Act (CAPTA Mental and behavioral health issues for children and youth in foster care Issues associated with the SNAP program S. 3196 -- Ensuring Medicaid Continuity for Children in Foster Care Act HR 2428 the Find and Protect Foster Youth Act HR 3058 the Recruiting Families Using Data Act of 2023 S. 3098 to expand the replacement of stolen EBT benefit under SNAP HR 7010 Increasing Access to Foster Care Through Age 21 Act (Chu) HR 7038 Guaranteed Income for Foster Youth Act (Garcia)
Client expense: Not reported · Firm income: $36,000
Government targets: Administration for Children & Families (ACF), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Social Security Administration (SSA), White House Office
21st Century Cures Act 2.0 340B Contract Pharmacy Policy 340B Drug Discount Program Accelerated Approval Alternative Funding Programs Buy American Executive Order Cancer Moonshot CBO modeling Cell, gene and radioligand therapies Co-pay accumulator programs COVID-19 Diversity in Clinical Trials Drug cost and pricing policy issues Drug Importation and counterfeiting policy issues Drug shortages policy issues FDA modernization policy issues Foreign manufacturing policy issues Genetically Targeted Technologies H.R. 1613, The Drug Price Transparency in Medicaid Act H.R. 198, Drug Pricing Transparency and Accountability Act H.R. 2534, PROTECT 340B Act of 2023 H.R. 2679, Pharmacy Benefits Manager Accountability Act H.R. 2880, Protecting Patients Against PBM Abuses Act H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R. 3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency H.R. 4822, Health Care Price Transparency Act of 2023 H.R. 5376, Inflation Reduction Act H.R. 5378, Lower Costs, More Transparency Act H.R. 5416, The Give Kids a Chance Act H.R. 830/S. 1375, HELP Co-pays Act Health industry vertical integration Inflation Reduction Act Implementation Medicaid Payment Reform Notice of Benefit Payment Parameters (NBPP) Orphan drug policy issues Outcomes based contracting/value based arrangements Patient assistance program policy issues PDUFA, BSUFA, GDUFA Pharmaceutical quality Pharmaceutical supply chain Pharmacy benefit manager policy issues Reauthorization of PAHPA S. 1131, Drug Price Transparency Act S. 1133, 340B Accountability Act S. 1246, SMART Prices Act S. 127, The Pharmacy Benefit Manager Transparency Act of 2023 S. 1339, Pharmacy Benefit Manager Reform Act S. 1542/H.R. 6283, Delinking Revenue from Unfair Gouging (DRUG) Act S. 1967, Patients Before Middlemen Act S. 2837, 340B Accountability Act 2021 S. 2973 Modernizing and Ensuring PBM Accountability (MEPA) Act S. 3131/H.R. 5539, ORPHAN Cures Act S. 476/HR. 5567 The Maintaining Investments in New Innovations (MINI) Act S. 652/H.R. 2630, Safe Step Act S. 79/H.R. 1717, Interagency Patent Coordination and Improvement Act of 2023 Step Therapy The Medicaid VBPs for Patients (MVP) Act Transparency policy issues
Client expense: $960,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
21st Century Cures Act 2.0 340B Contract Pharmacy Policy 340B Drug Discount Program Accelerated Approval Alternative Funding Programs Buy American Executive Order Cancer Moonshot CBO modeling Cell, gene and radioligand therapies Co-pay accumulator programs COVID-19 Diversity in Clinical Trials Drug cost and pricing policy issues Drug Importation and counterfeiting policy issues Drug shortages policy issues FDA modernization policy issues Foreign manufacturing policy issues Genetically Targeted Technologies H.R. 1613, The Drug Price Transparency in Medicaid Act H.R. 198, Drug Pricing Transparency and Accountability Act H.R. 2534, PROTECT 340B Act of 2023 H.R. 2679, Pharmacy Benefits Manager Accountability Act H.R. 2880, Protecting Patients Against PBM Abuses Act H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R. 3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency H.R. 4822, Health Care Price Transparency Act of 2023 H.R. 5376, Inflation Reduction Act H.R. 5378, Lower Costs, More Transparency Act H.R. 5416, The Give Kids a Chance Act H.R. 830/S. 1375, HELP Co-pays Act Health industry vertical integration Inflation Reduction Act Implementation Medicaid Payment Reform Notice of Benefit Payment Parameters (NBPP) Orphan drug policy issues Outcomes based contracting/value based arrangements Patient assistance program policy issues PDUFA, BSUFA, GDUFA Pharmaceutical quality Pharmaceutical supply chain Pharmacy benefit manager policy issues Reauthorization of PAHPA S. 1131, Drug Price Transparency Act S. 1133, 340B Accountability Act S. 1246, SMART Prices Act S. 127, The Pharmacy Benefit Manager Transparency Act of 2023 S. 1339, Pharmacy Benefit Manager Reform Act S. 1542/H.R. 6283, Delinking Revenue from Unfair Gouging (DRUG) Act S. 1967, Patients Before Middlemen Act S. 2837, 340B Accountability Act 2021 S. 2973 Modernizing and Ensuring PBM Accountability (MEPA) Act S. 3131/H.R. 5539, ORPHAN Cures Act S. 476/HR. 5567 The Maintaining Investments in New Innovations (MINI) Act S. 652/H.R. 2630, Safe Step Act S. 79/H.R. 1717, Interagency Patent Coordination and Improvement Act of 2023 Step Therapy The Medicaid VBPs for Patients (MVP) Act Transparency policy issues
Client expense: $860,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2023 · fourth_quarter · Family issues/Abortion/Adoption
Biden Administration NPRM on child welfare S. 2837 - Expanded Coverage for Former Foster Youth (Casey) S. 2836 - Foster Youth and Mental Health Act (Casey) S. 2849 - Fostering Success in Higher Education Act (Casey) HR 4531 - The Support Act -- provision related to Qualified Residential Treatment Programs (QRTPs) and the Institutions for Mental Diseases (IMD) exclusion HR 3852 - Create Accountable Respectful Environments (CARE) for children Act (Dunn) HR 5028 - Family Poverty is Not Child Neglect Act (Moore) Parental rights and gender-affirming care as it relates to foster care and CAPTA Reauthorization of Title IV-B of the SSA Implementation of the Family First Prevention Services Act (FFPSA) Interaction between Institutions for Mental Diseases (IMD) with Qualified Residential Treatment programs (QRTPs) -- HR 4056 H.R. 1446/S. 699 -- The Foster Youth and Driving Act Ensuring that children and youth in foster care have access to a Social Security Card H.R 4282 -- to protect individuals with disabilities who are parents, legal guardians, relatives, other caregivers, foster or adoptive parents, or individuals seeking to become foster or adoptive parents from discrimination on the child welfare system Issues associated with the reauthorization of the Child Abuse Prevention and Treatment Act (CAPTA Mental and behavioral health issues for children and youth in foster care Issues associated with the SNAP program S. 3196 -- Ensuring Medicaid Continuity for Children in Foster Care Act HR 2428 the Find and Protect Foster Youth Act HR 3058 the Recruiting Families Using Data Act of 2023 S. 3098 to expand the replacement of stolen EBT ben efirt under SNAP
Client expense: Not reported · Firm income: $36,000
Government targets: Administration for Children & Families (ACF), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Social Security Administration (SSA), White House Office
340B Drug Discount Program H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R. 2534, PROTECT 340B Act of 2023 340B Contract Pharmacy Policy S. 1133, 340B Accountability Act Accelerated Approval Advanced Research Projects Agency for Health (ARPA-H) Alternative Funding Programs Biosimilar approval and reimbursement policy issues Buy American Executive Order Cancer Moonshot Cell, gene and radioligand therapies Co-pay accumulator programs Diversity in Clinical Trials Drug cost and pricing policy issues Drug Importation and counterfeiting policy issues Drug shortages policy issues FDA modernization policy issues Foreign manufacturing policy issues Genetically Targeted Technologies H.R. 2534, Preserving Rules Ordered for the Entities Covered Through (PROTECT) 340B Act H.R. 2679, Pharmacy Benefits Manager Accountability Act H.R. 5376, Inflation Reduction Act H.R. 4822, Health Care Price Transparency Act of 2023 Inflation Reduction Act Implementation H.R. 5416, The Give Kids a Chance Act The Medicaid VBPs for Patients (MVP) Act H.R. 830/S. 1375, HELP Co-pays Act H.R. 1613, The Drug Price Transparency in Medicaid Act H.R. 198, Drug Pricing Transparency and Accountability Act H.R. 3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency Medicaid Payment Reform Notice of Benefit Payment Parameters (NBPP) Orphan drug policy issues Outcomes based contracting/value based arrangements Patient assistance program policy issues PDUFA, BSUFA, GDUFA Pharmaceutical quality Pharmaceutical supply chain Pharmacy benefit manager policy issues Priority Review Voucher (PRV) Reauthorization of PAHPA Regulatory efficiencies policy issues S. 652/H.R. 2630, Safe Step Act S. 79/H.R. 1717, Interagency Patent Coordination and Improvement Act of 2023 S. 2837, 340B Accountability Act 2021 S. 476/HR. 5567 The Maintaining Investments in New Innovations (MINI) Act H.R. 5539, ORPHAN Cures Act S. 1246, SMART Prices Act S. 127, The Pharmacy Benefit Manager Transparency Act of 2023 S. 1339, Pharmacy Benefit Manager Reform Act S. 1542, Delinking Reveue from Unfair Gouging (DRUG) Act S. 1967, Patients Before Middlemen Act S. 2973 Modernizing and Ensuring PBM Accountability (MEPA) Act H.R. 5378, Lower Costs, More Transparency Act H.R. 2880, Protecting Patients Against PBM Abuses Act Step Therapy Transparency policy issues Utilization management issues Health industry vertical integration CBO modeling 340B Program Implementation & Oversight 340B Accountability Act S. 1182: The 340B Reporting and Accountability Act H.R.2534: PROTECT 340B Act of 2023 H.R.2408: Access to Innovative Treatments Act of 2023 H.R.1790: Biologics Competition Act of 2023 S.113: Prescription Pricing for the People Act of 2023 S.150: Affordable Prescriptions for Patients Act of 2023 Drug Benefit Design
2023 · third_quarter · Family issues/Abortion/Adoption
Biden Administration NPRM on child welfare S. 2837 - Expanded Coverage for Former Foster Youth (Casey) S. 2836 - Foster Youth and Mental Health Act (Casey) S. 2849 - Fostering Success in Higher Education Act (Casey) HR 4531 - The Support Act -- provision related to Qualified Residential Treatment Programs (QRTPs) and the Institutions for Mental Diseases (IMD) exclusion HR 3852 - Create Accountable Respectful Environments (CARE) for children Act (Dunn) HR 5028 - Family Poverty is Not Child Neglect Act (Moore) Parental rights and gender-affirming care as it relates to foster care and CAPTA Reauthorization of Title IV-B of the SSA Implementation of the Family First Prevention Services Act (FFPSA) Interaction between Institutions for Mental Diseases (IMD) with Qualified Residential Treatment programs (QRTPs) -- HR 4056 H.R. 1446/S. 699 -- The Foster Youth and Driving Act Ensuring that children and youth in foster care have access to a Social Security Card H.R 4282 -- to protect individuals with disabilities who are parents, legal guardians, relatives, other caregivers, foster or adoptive parents, or individuals seeking to become foster or adoptive parents from discrimination on the child welfare system Issues associated with the reauthorization of the Child Abuse Prevention and Treatment Act (CAPTA)
Client expense: Not reported · Firm income: $36,000
340B Drug Discount Program 340B Accountability Act Accelerated Approval Advanced Research Projects Agency for Health (ARPA-H) Alternative Funding Programs Biosimilar approval and reimbursement policy issues BLOCKING Act Buy American Executive Order Cancer Moonshot Cell, gene and radioligand therapies Co-pay accumulator programs Diversity in Clinical Trials Drug cost and pricing policy issues Drug Importation and counterfeiting policy issues Drug shortages policy issues FDA modernization policy issues Foreign manufacturing policy issues Genetically Targeted Technologies H.R. 2534, Preserving Rules Ordered for the Entities Covered Through (PROTECT) 340B Act H.R. 2679, Pharmacy Benefits Manager Accountability Act H.R. 5376, Inflation Reduction Act Inflation Reduction Act Implementation H.R. 5416, The Give Kids a Chance Act The Medicaid VBPs for Patients (MVP) Act H.R. 830/S. 1375, HELP Co-pays Act H.R. 1613, The Drug Price Transparency in Medicaid Act H.R. 198, Drug Pricing Transparency and Accountability Act Medicaid Payment Reform Notice of Benefit Payment Parameters (NBPP) Orphan drug policy issues Outcomes based contracting/value based arrangements Part B Home Infusion Patient assistance program policy issues PDUFA, BSUFA, GDUFA Pharmaceutical quality Pharmaceutical supply chain Pharmacy benefit manager policy issues Priority Review Voucher (PRV) Reauthorization of PAHPA Regulatory efficiencies policy issues S. 652/H.R. 2630, Safe Step Act S. 79/H.R. 1717, Interagency Patent Coordination and Improvement Act of 2023 S. 2837, 340B Accountability Act 2021 S. 476, The Maintaining Investments in New Innovations (MINI) Act S. 1246, SMART Prices Act S. 127, The Pharmacy Benefit Manager Transparency Act of 2023 S. 1339, Pharmacy Benefit Manager Reform Act Step Therapy Transparency policy issues Utilization management issues H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program (Bucshon Bill) 340B Contract Pharmacy Policy
340B Drug Discount Program Accelerated Approval Alternative Funding Programs Biosimilar approval and reimbursement policy issues BLOCKING Act Cancer Moonshot Cell, gene and radioligand therapies Co-pay accumulator programs COVID-19 Diversity in Clinical Trials Drug cost and pricing policy issues Drug shortages policy issues FDA modernization policy issues Foreign manufacturing policy issues Genetically Targeted Technologies H.R, 2534 - Preserving Rules Ordered for the Entities Covered Through (PROTECT) 340B Act H.R. 5376 - Inflation Reduction Act Implementation H.R. 5416, The Give Kids a Chance Act The Medicaid VBPs for Patients (MVP) Act H.R. 830, HELP Co-pays Act H.R. 1613, The Drug Price Transparency in Medicaid Act Intellectual property Notice of Benefit Payment Parameters (NBPP) Orphan Drugs Outcomes based contracting/value based arrangements Patient assistance program policy issues PDUFA, BSUFA, GDUFA Pharmaceutical quality Pharmaceutical supply chain Pharmacy benefit manager policy issues Priority Review Voucher (PRV) Regulatory efficiencies policy issues S. 2837, 340B Accountability Act 2021 S. 476, The Maintaining Investments in New Innovations (MINI) Act S.127, The Pharmacy Benefit Manager Transparency Act of 2023 Transparency policy issues Utilization management policies Vaccines
Client expense: $2,440,000 · Firm income: Not reported
Client expense: $1,360,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
Government targets: Administration for Children & Families (ACF), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Social Security Administration (SSA)
Client expense: $930,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office